Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer

Published:2020-08 Issue: Volume:254 Page:116816
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Bian Pan,Dou Zhongling,Jia Zhaohui,Li Wensheng,Pan Dong

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. WNT signalling pathways as therapeutic targets in cancer;Anastas;Nat. Rev. Cancer,2013

2. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer;Bhola;J. Clin. Invest.,2013

3. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics;Bisson;Cell Res.,2009

4. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer;Bradley;Carcinogenesis,2014

5. TGF-beta: an emerging player in drug resistance;Brunen;Cell Cycle,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course;Diagnostic Pathology;2024-06-21

2. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA;Cell Death & Disease;2024-05-16

3. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?;International Journal of Surgery;2024-05-03

4. The role of UBR5 in tumor proliferation and oncotherapy;Gene;2024-05

5. ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via K48-linked ubiquitination;American Journal of Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3